HOLMDEL, N.J., June 30 /PRNewswire/ -- Sparta Systems, Inc. (Sparta), the maker of TrackWise(R) and the market leader in enterprise quality and compliance management software, today announced that Genzyme, a world-leading biotechnology company, has selected Sparta Systems to enhance its quality management program.
Genzyme purchased TrackWise to handle Corrective and Preventive Actions (CAPA) as well as deviations and investigations. The TrackWise solution was chosen to replace an existing solution and legacy systems due to its ease of use, extensive reporting capabilities, user interface and industry standard acceptance.
According to Dave Dentino, director, quality and technical operations systems at Genzyme Corporation, "TrackWise has already proven itself through user acceptance and ease of configuration. We have already realized a benefit through the ease with which the system enabled global harmonization of our business processes."
"We are pleased that Genzyme selected Sparta to provide a single, consolidated tool for managing the core elements of their quality management operation," said James E. McGowan, president and CEO, Sparta Systems. "TrackWise has become the industry standard due to its flexibility through configuration, ease of integration and unmatched functionality and we look forward to a future global deployment with Genzyme to all their manufacturing sites."
About Sparta Systems
Sparta Systems, Inc. is the industry leader for global quality and compliance management systems. Its TrackWise product is a Web-based enterprise software application used by quality, manufacturing, regulatory affairs and business professionals to manage quality, compliance issues and action items across the enterprise. The company has more than 14 years of experience and an extensive customer base in life sciences and other highly regulated industries. Sparta Systems offers its customers a complete solution for global quality management needs, including the on-site support required throughout the project lifecycle. More information about Sparta Systems and TrackWise can be found at http://www.sparta-systems.com.
One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenues of $3.8 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation.
With many established products and services helping patients in nearly
90 countries, Genzyme is a leader in the effort to develop and apply the
most advanced technologies in the life sciences. The company's products and
services are focused on rare inherited disorders, kidney disease,
orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's
commitment to innovation continues today with a substantial development
program focused on these fields, as well as immune disease, infectious
disease, and other areas of unmet medical need.
Director of Marketing
Sparta Systems, Inc.
Tel: 732-203-0400 x121
|SOURCE Sparta Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved